|
|
|
|
|
|
By Erin Harris, editor-in-chief, Cell & Gene | Here are some examples of what CGT leaders have shared with me and with Cell & Gene’s readers about developments in cell therapy. |
|
|
|
|
|
|
|
|
|
| How Different Are Oncology Clinical Trials? | Article | OpenClinica | Oncology clinical trials pose unique challenges. Dive into five key reasons behind the intricacies of oncology trials, from recruitment hurdles to data volume and efficacy endpoints. |
|
|
| Rev-Up AAV Genome Production In Upstream Manufacturing | Application Note | By Becky Reese, Jennifer Swanson, Austin Storck and Laura Juckem, Mirus Bio | By increasing recombinant AAV titers, this AAV enhancer can help reduce upstream manufacturing costs and lower the cost per therapeutic dose. |
|
|
|
|
|
|
|
|
|
Connect With Cell & Gene: |
|
|
|